News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

IBTA Newsletter

Al's Comment:
 From our friends at the IBTA!  This is the last issue Denis will contribute to as he is retiring.  He did a great job for years and I am sure Kathy will do a great job also!  Happy Retirement Denis!
 
This newsletter mentions 2 very important articles: One showing that Gliolan is better than intraoperative MRI. Gliolan is a dye that makes the tumor light up during surgery. It is approved in Europe but not available yet in the USA.
The other article is on the CTLA-4 blockade.  Worth reading!


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://www.theibta.org/ENewsMay2014.htm


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740